The patent badge is an abbreviated version of the USPTO patent document. The patent badge does contain a link to the full patent document.

The patent badge is an abbreviated version of the USPTO patent document. The patent badge covers the following: Patent number, Date patent was issued, Date patent was filed, Title of the patent, Applicant, Inventor, Assignee, Attorney firm, Primary examiner, Assistant examiner, CPCs, and Abstract. The patent badge does contain a link to the full patent document (in Adobe Acrobat format, aka pdf). To download or print any patent click here.

Date of Patent:
Mar. 07, 2023

Filed:

Oct. 23, 2019
Applicant:

Mabplex International Co., Ltd., Shandong, CN;

Inventors:

Lele Li, Shandong, CN;

Changjiang Huang, Shandong, CN;

Youxiang Sun, Shandong, CN;

Lina Liu, Shandong, CN;

Assignee:

MABPLEX INTERNATIONAL CO., LTD, China (Shandong) Pilot Free Trade Zone, CN;

Attorney:
Primary Examiner:
Int. Cl.
CPC ...
A61K 47/68 (2017.01);
U.S. Cl.
CPC ...
A61K 47/6801 (2017.08); A61K 47/6855 (2017.08); A61K 47/6889 (2017.08);
Abstract

Provided is an antibody-drug conjugate (ADC) using one or more cysteine or derivatives thereof as linkers to couple one or more drugs at the limited binding sites of an antibody, making it possible to produce an ADC product with high drug payload, or to choose a drug with less toxicity, thereby obtaining an ADC product with wide therapeutic window. In addition, since a plurality of drugs may be coupled to one binding site, the ADC products obtained by the method of the present disclosure have better uniformity in the case of same DAR value. Moreover, the amount of antibody required for production may be greatly reduced, thereby lowering the cost. Compared with the antibody-drug conjugates coupled only one drug, the antibody-drug conjugates produced by the method of the present disclosure have the same inhibition or killing effect on tumor cells while using fewer drugs for coupling to the same site.


Find Patent Forward Citations

Loading…